Diseases of the Musculoskeletal System | Diseases of the Nervous System

Registry of Patients With Generalized Myasthenia Gravis Who Have Ever Been Treated With C5 Inhibition Therapies

Volunteers
Health Professionals

What is the purpose of this trial?

If you have generalized myasthenia gravis (gMG) and have been treated with complement component 5 inhibition therapies (C5IT) you may be eligible to participate in a registry to see how well C5IT treats gMG over time, and to help us learn more about the safety of this therapy.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Danielle Carlson

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Richard Nowak, MD, MS
Associate Professor of Neurology; Director, Program in Clinical & Translational Neuromuscular Research; Director, Yale Myasthenia Gravis Clinic

Sub-Investigator

Bhaskar Roy, MBBS, MHS

Last Updated
11/20/2023
Study HIC
#2000026785REG